Knight, Matthew J.
Yu, Yuan
Chen, Jiacheng
O’Brien, Sheila F.
Buckeridge, David L.
Charlton, Carmen
Russell, W. Alton
Funding for this research was provided by:
Canadian Blood Services (N/A)
COVID-19 Immunity Task Force (N/A)
Article History
Received: 5 January 2025
Accepted: 29 April 2025
First Online: 3 June 2025
Declarations
:
: This secondary analysis of de-identified demographic data was approved by the McGill University Faculty of Medicine and Health Sciences Research Ethics Board (study number 22-03-077) and conducted in accordance with the Declaration of Helsinki. The Research Ethics Board waived the need to obtain informed consent to participate from study participants for this secondary analysis. The six studies that collected primary data analyzed in this report were each approved by one or more Research Ethics Board or Institutional Review Board of a Canadian institution, as previously reported. All experiments were conducted in compliance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.